Delivery Order SPE2DB20D1100-SPE2DB24FD0N2

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Lacosamide 10 mg/ml solution in 200 ml containers, valued at $1,292.14. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is October 21, 2024. The contract was not set aside for any specific business category. This award is associated with a larger Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of a specific medication - Lacosamide 10 mg/ml Solution 200ml. The contract is a Delivery Order valued at $1,853.59 and has a completion date of July 30, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with various federal agencies, including a $999,999,999 IDC...
This federal contract award, valued at $1,254.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The award is for the delivery of Lacosamide 10 mg/ml Solution 200 ml, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of September 23, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,072.37 for the supply of Lacosamide 10 mg/ml solution. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 22, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $7,970.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the delivery of Lacosamide 10 mg/ml solution in 200 ml containers. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,032.18, is a Firm Fixed Price Delivery Order for the supply of Lacosamide 10 mg/ml solution in 200 ml bottles. The contract has an ultimate completion date of January 13, 2025 and was awarded on January 10, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,361.54 Firm Fixed Price Delivery Order contract is for the supply of Lacosamide 10 mg/ml solution, a specialty medication. The contract has a period of performance through June 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,118.64, is for the delivery of Lacosamide 10 mg/ml solution in 200 ml containers. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $1,902.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lacosamide 10 mg/ml solution, a pharmaceutical product, with a completion date of December 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,333.48 firm-fixed-price delivery order is for the supply of Lacosamide 10 mg/ml solution, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD0N2
    Delivery Order

This federal contract award is for the supply of Lacosamide 10 mg/ml solution, a prescription medication, to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp. The contract is a delivery order with a firm fixed-price of $2,517.72 and an ultimate completion date of August 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as well as multiple Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation for a wide range of medical commodities, including critical care supplies and prescription drugs. These contract vehicles allow government agencies to efficiently procure essential pharmaceutical and medical products to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. This award does not have a set-aside designation.

Generated 10/31/24, 10:43 AM